{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:25:37Z","timestamp":1762107937561,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["402417\/2023-2"],"award-info":[{"award-number":["402417\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","award":["APQ-02167-21","RED-0067-23"],"award-info":[{"award-number":["APQ-02167-21","RED-0067-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cellimm.2025.104949","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:21:00Z","timestamp":1743942060000},"page":"104949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasis"],"prefix":"10.1016","volume":"411-412","author":[{"given":"Daniela P.","family":"Lage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danniele L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela G.P.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana A.M.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel J.L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela D.","family":"Oleg\u00e1rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via C.","family":"Rizzatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breno L.","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina O.M.","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saulo S.G.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.B.","family":"C\u00e2mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela A.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.","family":"Machado-de-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexsandro S.","family":"Galdino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Leishmaniasis","key":"10.1016\/j.cellimm.2025.104949_bb0005"},{"issue":"3","key":"10.1016\/j.cellimm.2025.104949_bb0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"issue":"10151","key":"10.1016\/j.cellimm.2025.104949_bb0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"Burza","year":"2018","journal-title":"Leishmaniasis. Lancet."},{"issue":"8","key":"10.1016\/j.cellimm.2025.104949_bb0020","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.cellimm.2025.104949_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104949_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1586\/14760584.2014.894467","article-title":"Identifying vaccine targets for anti-leishmanial vaccine development","volume":"13","author":"Sundar","year":"2014","journal-title":"Expert Rev. Vaccines"},{"issue":"4","key":"10.1016\/j.cellimm.2025.104949_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"issue":"13","key":"10.1016\/j.cellimm.2025.104949_bb0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2174\/0113894501254585230927100440","article-title":"Review on the drug intolerance and vaccine development for the Leishmaniasis","volume":"24","author":"Kumari","year":"2023","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.cellimm.2025.104949_bb0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors"},{"issue":"11","key":"10.1016\/j.cellimm.2025.104949_bb0050","article-title":"Role of cytokines in experimental and human visceral Leishmaniasis","volume":"18","author":"Samant","year":"2021","journal-title":"FronT-cell Infect Microbiol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0055","doi-asserted-by":"crossref","first-page":"1063291","DOI":"10.3389\/fcimb.2022.1063291","article-title":"Humoral response in Leishmaniasis","volume":"12","author":"Conde","year":"2022","journal-title":"FronT-cell Infect Microbiol."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104949_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/0037-8682-0022-2012","article-title":"Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis","volume":"46","author":"Bhattacharya","year":"2013","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"13","key":"10.1016\/j.cellimm.2025.104949_bb0065","article-title":"T lymphocyte exhaustion during human and experimental visceral Leishmaniasis","volume":"2","author":"Costa-Madeira","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral leishmaniasis: a review","volume":"422","author":"Jain","year":"2015","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.cellimm.2025.104949_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/vaccines12030271","article-title":"New approaches to the prevention of visceral Leishmaniasis: a review of recent patents of potential candidates for a chimeric protein vaccine","volume":"12","author":"Oliveira","year":"2024","journal-title":"Vaccines (Basel)."},{"issue":"20","key":"10.1016\/j.cellimm.2025.104949_bb0080","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2021.04.004","article-title":"A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB\/c mice","volume":"39","author":"Ostolin","year":"2021","journal-title":"Vaccine"},{"issue":"323","key":"10.1016\/j.cellimm.2025.104949_bb0085","article-title":"Cloning, expression and in vitro validation of chimeric multi epitope vaccine candidate against visceral leishmaniasis infection","volume":"15","author":"Ojha","year":"2023","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.cellimm.2025.104949_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-020-00224-0","article-title":"A candidate vaccine for human visceral leishmaniasis based on a specific T-cell epitope-containing chimeric protein protects mice against Leishmania infantum infection","volume":"13","author":"Lage","year":"2020","journal-title":"NPJ Vaccines."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104949_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.vaccine.2020.11.064","article-title":"Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: a new promising vaccine against visceral leishmaniasis","volume":"39","author":"Emerick","year":"2021","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.cellimm.2025.104949_bb0100","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/microorganisms9112253","article-title":"Protective efficacy in a Hamster model of a multivalent vaccine for human visceral Leishmaniasis (MuLeVaClin) consisting of the KMP11, LEISH-F3+, and LJL143 antigens in Virosomes, plus GLA-SE adjuvant","volume":"9","author":"Fern\u00e1ndez","year":"2021","journal-title":"Microorganisms"},{"issue":"27","key":"10.1016\/j.cellimm.2025.104949_bb0105","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: an overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cellimm.2025.104949_bb0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/acsabm.8b00184","article-title":"Monophosphoryl lipid a based cationic liposome facilitates vaccine induced expansion of Polyfunctional T-cell immune responses against visceral Leishmaniasis","volume":"1","author":"Das","year":"2018","journal-title":"ACS Appl. Bio Mater."},{"issue":"Pt 1","key":"10.1016\/j.cellimm.2025.104949_bb0115","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","article-title":"Chitosan coated PluronicF127 micelles for effective delivery of amphotericin B in experimental visceral leishmaniasis","volume":"105","author":"Singh","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155865","article-title":"Recombinant guanosine-5\u2032-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection","volume":"153","author":"Lage","year":"2022","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cellimm.2025.104949_bb0125","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104949_bb0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0463.2012.02968.x","article-title":"Enhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major","volume":"121","author":"Ghaffarifar","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.cellimm.2025.104949_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2020.06.010","article-title":"Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis","volume":"124","author":"Oliveira-da-Silva","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0140","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2025.104949_bb0145","article-title":"TepiTool: a pipeline for computational prediction of T-cell epitope candidates","volume":"114","author":"Paul","year":"2016","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0150","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cellimm.2025.104949_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cellimm.2025.104949_bb0160","article-title":"The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024. Nucleic Acids Research","author":"Madeira","year":"2024","journal-title":"Apr:gkae241"},{"key":"10.1016\/j.cellimm.2025.104949_bb0165","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: the proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.cellimm.2025.104949_bb0170","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","article-title":"Protein-sol: a web tool for predicting protein solubility from sequence","volume":"33","author":"Hebditch","year":"2017","journal-title":"Bioinformatics"},{"issue":"2021","key":"10.1016\/j.cellimm.2025.104949_bb0175","doi-asserted-by":"crossref","first-page":"8845826","DOI":"10.1155\/2021\/8845826","article-title":"A chimera of Th1 stimulatory proteins of Leishmania donovani offers moderate immunotherapeutic efficacy with a Th1-inclined immune response against visceral Leishmaniasis","volume":"27","author":"Ratnapriya","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cellimm.2025.104949_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155320","article-title":"Cytokines in the immunity and immunopathogenesis in leishmaniases","volume":"145","author":"Saha","year":"2021","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cellimm.2025.104949_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BST20200606","article-title":"Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis","volume":"49","author":"Pacheco-Fernandez","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"10","key":"10.1016\/j.cellimm.2025.104949_bb0190","article-title":"IL-10 and TGF-beta induced arginase expression contributes to deficient nitric oxide response in human visceral Leishmaniasis","volume":"18","author":"Kupani","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.cellimm.2025.104949_bb0195","article-title":"Role of cytokines in experimental and human visceral Leishmaniasis","volume":"18","author":"Samant","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.cellimm.2025.104949_bb0200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/vaccines11020395","article-title":"The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection","volume":"11","author":"Mathias","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cellimm.2025.104949_bb0205","article-title":"A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis","volume":"380","author":"Valentim","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106986","article-title":"The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice","volume":"246","author":"Lage","year":"2023","journal-title":"Acta Trop."},{"issue":"8","key":"10.1016\/j.cellimm.2025.104949_bb0215","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/eji.201242428","article-title":"TLR-mediated distinct IFN-gamma\/IL-10 pattern induces protective immunity against murine visceral leishmaniasis","volume":"42","author":"Paul","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104949_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152085","article-title":"Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis","volume":"226","author":"Zhang","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2025.104949_bb0225","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","article-title":"Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides","volume":"103","author":"Agallou","year":"2018","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2025.104949_bb0235","article-title":"Resistance to experimental visceral Leishmaniasis in mice infected with Leishmania infantum requires Batf3","volume":"10","author":"Soto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2025.104949_bb0240","first-page":"17","article-title":"Sustained parasite burden in the spleen of Leishmania infantum-infected BALB\/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge","volume":"1","author":"Rousseau","year":"2001","journal-title":"Eur. Cytokine Netw."},{"issue":"8","key":"10.1016\/j.cellimm.2025.104949_bb0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1590\/0074-02760160529","article-title":"Protection mediated by chemokine CXCL10 in BALB\/c mice infected by Leishmania infantum","volume":"112","author":"Figueiredo","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.cellimm.2025.104949_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105021","article-title":"Potential of TLR agonist as an adjuvant in Leishmania vaccine against visceral leishmaniasis in BALB\/c mice","volume":"158","author":"Goyal","year":"2021","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.cellimm.2025.104949_bb0255","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/jbm.b.33965","article-title":"3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine","volume":"106","author":"Wang","year":"2018","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"12","key":"10.1016\/j.cellimm.2025.104949_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003391","article-title":"DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T-cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant","volume":"8","author":"Bayih","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.cellimm.2025.104949_bb0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2011.07.001","article-title":"Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB\/c mice: the contribution of toll-like receptor agonists as adjuvant","volume":"129","author":"Daifalla","year":"2011","journal-title":"Exp. Parasitol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:24:02Z","timestamp":1762107842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874925000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":53,"alternative-id":["S0008874925000346"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.104949","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.104949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104949"}}